Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Scapular Mobilization Added to Conventional Exercise in Ankylosing Spondylitis

13. november 2026 opdateret af: Elif Umay Altas, Izmir Bakircay University

The Effect of Scapular Mobilization Added to Conventional Exercises on Respiratory Function, Posture, and Quality of Life in Patients With Ankylosing Spondylitis: A Randomized Controlled Trial

Ankylosing spondylitis (AS) is a chronic inflammatory disease of the axial skeleton that commonly leads to restricted spinal mobility, postural deformities such as thoracic hyperkyphosis, and reduced chest wall expansion, which can impair respiratory function and quality of life. Exercise is the cornerstone of rehabilitation in AS, and manual therapy techniques may provide additional benefit by restoring mobility of the thoracic cage and shoulder girdle.

The aim of this randomized controlled, single-blind trial is to investigate whether scapular mobilization added to a conventional exercise program improves chest expansion and respiratory function (primary outcomes), as well as pain, disease activity, function, spinal mobility, posture, exercise capacity, and quality of life (secondary outcomes) in patients with AS. Thirty-four patients will be randomly allocated to either scapular mobilization plus conventional exercise or conventional exercise alone, 3 sessions per week for 8 weeks (24 sessions). Outcomes will be assessed at baseline, after treatment (week 8), and at month 3.

Studieoversigt

Detaljeret beskrivelse

Background: AS is a chronic inflammatory disease most frequently seen in young men, involving the spine, sacroiliac joints, peripheral joints, and entheses, and causing pain, stiffness, functional impairment, and postural abnormalities. Dysfunction of the thoracic spine and scapular region not only causes pain and limited movement but also restricts chest wall mobility, which may reduce ventilatory efficiency and quality of life. Previous studies have shown that thoracic mobilization exercises improve kyphosis and respiratory function (FVC, FEV1), aerobic exercise improves disease activity and respiratory muscle strength, and manual therapy added to exercise provides superior improvements in chest expansion and functional capacity. However, evidence on the specific added contribution of scapular mobilization to standard exercise programs is limited.

Design: Prospective, randomized, controlled, single-blind, parallel-group trial conducted at the Physical Medicine and Rehabilitation outpatient clinic of Izmir Bakircay University Cigli Training and Research Hospital.

Sample size: Based on Acharya et al. (2024), with an effect size of Cohen's d = 0.40, alpha = 0.05, power = 80%, a two-group repeated-measures design with three time points and a correlation of 0.3 between repeated measures, the minimum sample size is 30 (15 per group). Allowing for a 10% dropout rate, 34 participants (17 per group) will be enrolled.

Interventions: Both groups will receive the same progressive conventional exercise program (30 minutes per session, 3 sessions/week, 8 weeks, 24 sessions), supervised by the same physiotherapist. The experimental group will additionally receive approximately 20 minutes of scapular mobilization per session.

Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Progression: Weeks 1-2 (initial level: movement learning, low-intensity mobility, breathing, stretching and low-resistance strengthening; 8-10 repetitions, 1-2 sets, slow tempo); weeks 3-5 (intermediate: increased repetitions and sets, dynamic movements, moderate elastic band resistance, breathing combined with arm movements; 10-15 repetitions, 2-3 sets, moderate tempo); weeks 6-8 (advanced: higher resistance, multi-joint functional movements, dynamic balance and coordination, increased aerobic duration; 12-15 repetitions, 3 sets, moderate-to-high tempo). Progression requires correct form, no increase in pain (VAS) during exercise, return of symptoms to baseline within 24 hours, and improved functional performance. Regression to the previous level occurs with increased pain, prolonged fatigue, postural deterioration, or compensatory movement patterns.

Scapular mobilization: Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Assessments: Demographic and clinical data (age, sex, height, weight, education, occupation, smoking/alcohol, family history, diagnosis year, symptom duration, medications and duration of use, extra-articular involvement, previous surgery, exercise habits) will be recorded. Outcome measures (VAS, BASDAI, BASFI, BASMI, ASQoL, chest expansion, spirometry, 6-minute walk test, thoracic kyphosis angle by digital inclinometer) will be assessed at baseline, after treatment (week 8), and at month 3.

Hypotheses: H0 - Scapular mobilization added to routine exercises has no effect on pain, posture, respiratory function, and quality of life in patients with AS. H1 - Scapular mobilization added to routine exercises has an effect on these parameters.

Statistical analysis: SPSS version 20.0 will be used, with p < 0.05 considered significant. Normality will be tested with the Kolmogorov-Smirnov test. Repeated-measures ANOVA will be used for parametric data; Friedman and Wilcoxon signed-rank tests for non-parametric data. Categorical variables will be compared using the chi-square test.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

34

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Izmir, Tyrkiet (Türkiye), 35620
        • Izmir Bakircay University Cigli Training and Research Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

30 år til 60 år (Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Diagnosis of ankylosing spondylitis according to the modified New York criteria
  • Age between 30 and 60 years
  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score of 4.0 or lower
  • Pulmonary function test performed within the last month

Exclusion Criteria:

  • Regular exercise during the previous 3 months
  • Spinal ankylosis
  • Cardiovascular, pulmonary, orthopedic, or neurological conditions that may prevent exercise (uncontrolled hypertension, history of myocardial infarction or coronary revascularization, history of syncope or exercise-related arrhythmia, decompensated type 1 diabetes mellitus, history of hip and/or knee arthroplasty)
  • Any surgery within the last 6 months
  • Active disease flare within the last 3 months
  • Communication problems
  • Any other respiratory or neuromuscular disease that may affect the respiratory muscles

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Scapular Mobilization + Conventional Exercise

Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Performed by a physiotherapist with the patient in side-lying. The therapist grasps the superior and inferior angles of the scapula to apply superior-inferior glides, followed by upward and downward rotation mobilizations. Then, grasping the inferior angle and medial border with both hands, the therapist tilts the scapula away from the thoracic wall while applying scapular distraction. Each technique is applied as 3 sets of 10 repetitions (6 seconds per cycle) with 30 seconds of rest between sets (Maitland approach).

Andre navne:
  • Maitland scapular mobilization

posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Andre navne:
  • Standard exercise therapy
Aktiv komparator: Conventional Exercise

Conventional exercise program: posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

posture and patient education (spinal alignment, deep spinal muscle activation, chin-tuck position); warm-up and cool-down (active range-of-motion exercises, 10 repetitions each); stretching (hamstrings, pectorals, child's pose for thoracolumbar flexion; 30 s x 2 repetitions); mobility exercises (hook-lying lateral flexion to heels, cat-camel, side-lying thoracic rotation with arm movement); strengthening exercises (bridge, mini squat, prone Y/T/W, wall towel slide, resisted serratus punch, bird-dog, clamshell); and breathing exercises (unilateral, bilateral, apical, and posterior basal thoracic expansion exercises; segmental costal breathing; thoracic expansion combined with upper-extremity elevation).

Andre navne:
  • Standard exercise therapy

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Chest Expansion
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Forced Vital Capacity (FVC)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Forced Expiratory Volume in 1 Second (FEV1)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
FEV1/FVC Ratio
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3

Sekundære resultatmål

Resultatmål
Tidsramme
Peak Expiratory Flow (PEF)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Thoracic Pain Intensity (Visual Analog Scale)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Disease Activity (BASDAI)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Functional Status (BASFI)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Spinal Mobility (BASMI)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Quality of Life (ASQoL)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Thoracic Kyphosis Angle
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3
Functional Exercise Capacity (6-Minute Walk Test)
Tidsramme: Baseline, week 8 (end of treatment), and month 3
Baseline, week 8 (end of treatment), and month 3

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Elif Umay Altaş, Izmir Bakircay University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

16. november 2026

Primær færdiggørelse (Anslået)

16. november 2027

Studieafslutning (Anslået)

25. november 2027

Datoer for studieregistrering

Først indsendt

13. november 2026

Først indsendt, der opfyldte QC-kriterier

13. november 2026

Først opslået (Faktiske)

18. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified individual participant data will not be made publicly available but can be shared with qualified researchers upon reasonable request to the principal investigator.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner